Biotechnology Assets Stock Forward View - Accumulation Distribution
| BST Stock | 0.20 0.02 9.09% |
Biotechnology Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Biotechnology Assets stock prices and determine the direction of Biotechnology Assets SA's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Biotechnology Assets' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the value of rsi of Biotechnology Assets' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Biotechnology Assets hype-based prediction, you can estimate the value of Biotechnology Assets SA from the perspective of Biotechnology Assets response to recently generated media hype and the effects of current headlines on its competitors.
Biotechnology Assets after-hype prediction price | EUR 0.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biotechnology |
Biotechnology Assets Additional Predictive Modules
Most predictive techniques to examine Biotechnology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biotechnology using various technical indicators. When you analyze Biotechnology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Biotechnology Assets Volatility | Backtest Biotechnology Assets | Information Ratio |
Biotechnology Assets Trading Date Momentum
| On February 05 2026 Biotechnology Assets SA was traded for 0.20 at the closing time. The maximum traded price for the trading interval was 0.20 and the lowest daily price was 0.20 . The daily volume was recorded at 88.5 K. The volume of trading on 5th of February 2026 did not affect price variability. The overall trading delta to the closing price today is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Biotechnology Assets to competition |
Other Forecasting Options for Biotechnology Assets
For every potential investor in Biotechnology, whether a beginner or expert, Biotechnology Assets' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biotechnology Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biotechnology. Basic forecasting techniques help filter out the noise by identifying Biotechnology Assets' price trends.Biotechnology Assets Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Assets stock to make a market-neutral strategy. Peer analysis of Biotechnology Assets could also be used in its relative valuation, which is a method of valuing Biotechnology Assets by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biotechnology Assets Market Strength Events
Market strength indicators help investors to evaluate how Biotechnology Assets stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biotechnology Assets shares will generate the highest return on investment. By undertsting and applying Biotechnology Assets stock market strength indicators, traders can identify Biotechnology Assets SA entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 0.2 | |||
| Day Typical Price | 0.2 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
Biotechnology Assets Risk Indicators
The analysis of Biotechnology Assets' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biotechnology Assets' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biotechnology stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.61 | |||
| Standard Deviation | 3.44 | |||
| Variance | 11.8 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biotechnology Assets
The number of cover stories for Biotechnology Assets depends on current market conditions and Biotechnology Assets' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biotechnology Assets is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biotechnology Assets' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Biotechnology Stock
Biotechnology Assets financial ratios help investors to determine whether Biotechnology Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Assets security.